Benefits of multi-day ex situ perfusion include dampened ischemia reperfusion injury in liver transplantation

Abstract

Section snippets

Authors' contributions

Study design: F.H., M.P. J.B. M.W.T., P.-A.C. Funding Acquisition: M.W.T., P.-A. C. Data collection: F.H., M.P., J.B. Data analysis: F.H., M.P., J.B. Manuscript writing: F.H., M.P., J.B. Manuscript review: all authors reviewed and approved the final version of the manuscript for submission.

Financial support

Research was supported by the Wyss Zurich Translational Center, the FZ-Healthcare Foundation, the Liver and Gastrointestinal Disease Foundation and an ETH Zurich Research Grant.

Declaration of Competing Interest

P.-A.C. is co-inventor on patents related to long-term machine perfusion. M.W.T. and P.-A.C. are co-founders of Apersys AG, that aims to commercialize long-term perfusion technologies.